Cargando…

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

PURPOSE: Cycloserine has been used in multidrug-resistant tuberculosis (MDR-TB) treatment since the 1950s. We evaluated the efficacy and safety of cycloserine and sought to clarify the role of cycloserine for treatment of simple MDR-TB, pre-extensively drug-resistant tuberculosis (pre-XDR-TB), and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Wang, Fei, Wu, Limin, Zhu, Min, He, Guiqing, Chen, Xinchang, Sun, Feng, Liu, Qihui, Wang, Xiaomeng, Zhang, Wenhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445236/ https://www.ncbi.nlm.nih.gov/pubmed/30992677 http://dx.doi.org/10.2147/IDR.S195555

Ejemplares similares

Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
por: Wang, Jing, et al.
Publicado: (2019)

Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing
por: Chen, Xinchang, et al.
Publicado: (2020)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021)

Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China
por: Chen, Xinchang, et al.
Publicado: (2019)

Corrigendum: Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China
por: Chen, Xinchang, et al.
Publicado: (2019)

High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China
por: Pang, Yu, et al.
Publicado: (2022)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis - A Case Report
por: Yadav, Sankalp
Publicado: (2022)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
por: Alghamdi, Wael A., et al.
Publicado: (2019)

Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance
por: Nakatani, Yoshio, et al.
Publicado: (2017)

Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
por: Wang, Jianjie, et al.
Publicado: (2020)

Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study
por: Li, Qingchun, et al.
Publicado: (2020)

Cycloserine induced mania
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
por: Desjardins, Christopher A., et al.
Publicado: (2016)

Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015
por: Li, Qingchun, et al.
Publicado: (2020)

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
por: Li, Yang, et al.
Publicado: (2018)

Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study
por: Ma, Jin-Bao, et al.
Publicado: (2022)

Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis
por: Mulubwa, Mwila, et al.
Publicado: (2019)

Structure of the d-Cycloserine-Resistant Variant D322N of Alanine Racemase from Mycobacterium tuberculosis
por: de Chiara, Cesira, et al.
Publicado: (2023)

Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study
por: Zhang, Yang, et al.
Publicado: (2017)

Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium
por: Wang, Ruibai, et al.
Publicado: (2022)

Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study
por: Du, Liang, et al.
Publicado: (2021)

Cycloserine induced psychosis with hepatic dysfunction
por: Tandon, Vishal R., et al.
Publicado: (2015)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
por: He, Guang Xue, et al.
Publicado: (2011)

Social support received by multidrug-resistant tuberculosis patients and related factors: a cross-sectional study in Zhejiang Province, People’s Republic of China
por: Chen, Bin, et al.
Publicado: (2016)

Neuroleptic malignant syndrome in cycloserine-induced psychosis
por: Sawant, Neena S., et al.
Publicado: (2015)

Transmission of multidrug-resistant Mycobacterium tuberculosis in Wuhan, China: A retrospective molecular epidemiological study
por: Duan, Qionghong, et al.
Publicado: (2022)

Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis
por: Prosser, Gareth A., et al.
Publicado: (2013)

Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China
por: Song, Zexuan, et al.
Publicado: (2023)

Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study
por: Lecai, Ji, et al.
Publicado: (2023)

Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China
por: Zhang, Ming-Wu, et al.
Publicado: (2021)

Effect of Mixed Infections with Mycobacterium tuberculosis and Nontuberculous Mycobacteria on Diagnosis of Multidrug-Resistant Tuberculosis: A Retrospective Multicentre Study in China
por: Huang, Mingxiang, et al.
Publicado: (2022)

Incidence Density and Predictors of Multidrug-Resistant Tuberculosis Among Individuals With Previous Tuberculosis History: A 15-Year Retrospective Cohort Study
por: Cheng, Qinglin, et al.
Publicado: (2021)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
por: Xu, Kaijin, et al.
Publicado: (2014)

Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB
por: Lee, Seung Heon, et al.
Publicado: (2015)

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
por: Schade, Sebastian, et al.
Publicado: (2015)

Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China
por: Li, Chun-Hua, et al.
Publicado: (2023)

Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study
por: Jiang, Weixi, et al.
Publicado: (2021)

Transmission of multidrug-resistant tuberculosis in Beijing, China: An epidemiological and genomic analysis
por: Yin, Jinfeng, et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5r7vt8du2v7sbvpmio84vvkumq